Urgent.News

What's breaking now, across thousands of outlets.

Science

Making the case for independent science

Hungarian Prime Minister Viktor Orbán's 16-year rule ended in the spring, when voters replaced him with Péter Magyar, who has pledged to undo Orbán-led initiatives that, in the eyes of critics, isolated and politicized science.

Making the case for independent science

This article explores the importance of maintaining independent science, particularly in light of Hungary's recent political changes. Prime Minister Viktor Orbán ruled for 16 years, but his government's actions have isolated and politicized science. Albert-László Barabási, a prominent scientist and professor, has outlined a plan for President Péter Magyar to reverse these trends.

Hungary boasts a strong scientific tradition, with numerous Nobel laureates and contributions to various fields. However, the Orbán regime intervened in Hungary's research institutions and national labs, removing them from the control of the Hungarian Academy of Sciences. This shift has created psychological distance and undermined the scientific community's cohesion. Despite increased funding and resources, the psychological impact of losing academic control proved difficult to overcome.

The Orbán government attempted to address this by creating independent foundations to fund universities, but these foundations were controlled by political appointees. This effectively politicized research funding and limited collaboration with international peers. The EU has recognized these issues, protesting Hungary's universities' exclusion from the Erasmus program and European funding.

Restoring independent research governance is crucial for rebuilding trust and scientific capacity. Barabási emphasizes the need for transparent decision-making and sustained funding to address Hungary's scientific challenges. While the direction appears positive, the outcome will depend on the new government's commitment to maintaining scientific independence.

Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at phys.org →

More in Science

Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development

Through its entry into Lilly Gateway Labs, Rznomics officials say they plan to accelerate candidate discovery and development across its target gene database bank comprising over 200 disease targets. The post Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development appeared first on GEN - Genetic…

  • Rznomics partners with Lilly Gateway Labs to speed up RNA therapeutic development
  • Collaboration focuses on expanding target gene database and global clinical infrastructure
  • CEO Seong-Wook Lee sees partnership as major step for RNA platform

More from Monday 24 August →